These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17484770)

  • 1. Lipopolysaccharide enhances in vivo interleukin-2 production and proliferation by naive antigen-specific CD4 T cells via a Toll-like receptor 4-dependent mechanism.
    Costalonga M; Zell T
    Immunology; 2007 Sep; 122(1):124-30. PubMed ID: 17484770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells restrain CD4+ T cells from causing unregulated immune activation and hypersensitivity to lipopolysaccharide challenge.
    Okeke EB; Okwor I; Uzonna JE
    J Immunol; 2014 Jul; 193(2):655-62. PubMed ID: 24943218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 acts on antigen-presenting cells to enhance the in vivo proliferation of antigen-stimulated naive CD4 T cells via a CD28-dependent mechanism that does not involve increased expression of CD28 ligands.
    Khoruts A; Osness RE; Jenkins MK
    Eur J Immunol; 2004 Apr; 34(4):1085-90. PubMed ID: 15048719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of antigen-specific T cell activation in vivo in response to intracerebral administration of a xenopeptide.
    Ni HT; Merica RR; Spellman SR; Wang JM; Low WC
    Exp Neurol; 2000 Aug; 164(2):362-70. PubMed ID: 10915575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion and degranulation-promoting adapter protein (ADAP) positively regulates T cell sensitivity to antigen and T cell survival.
    Mueller KL; Thomas MS; Burbach BJ; Peterson EJ; Shimizu Y
    J Immunol; 2007 Sep; 179(6):3559-69. PubMed ID: 17785790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of enhanced antigen presentation by B cells activated with anti-mu plus interferon-gamma: role of B7-2 in the activation of naive and memory CD4+ T cells.
    Morokata T; Kato T; Igarashi O; Nariuchi H
    Eur J Immunol; 1995 Jul; 25(7):1992-8. PubMed ID: 7542599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-derived lipopolysaccharide promotes T-cell-mediated hepatitis in mice through Toll-like receptor 4.
    Lin Y; Yu LX; Yan HX; Yang W; Tang L; Zhang HL; Liu Q; Zou SS; He YQ; Wang C; Wu MC; Wang HY
    Cancer Prev Res (Phila); 2012 Sep; 5(9):1090-102. PubMed ID: 22617167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro production of antigen-specific T cells from unprimed mice: role of dexamethasone and anti-IL-10 antibodies.
    Dozmorov I; Miller RA
    Cell Immunol; 1997 Jun; 178(2):187-96. PubMed ID: 9225010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
    Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
    Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant contraction of antigen-specific CD4 T cells after infection in the absence of gamma interferon or its receptor.
    Haring JS; Harty JT
    Infect Immun; 2006 Nov; 74(11):6252-63. PubMed ID: 16966404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide.
    Caramalho I; Lopes-Carvalho T; Ostler D; Zelenay S; Haury M; Demengeot J
    J Exp Med; 2003 Feb; 197(4):403-11. PubMed ID: 12591899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells.
    Thompson BS; Chilton PM; Ward JR; Evans JT; Mitchell TC
    J Leukoc Biol; 2005 Dec; 78(6):1273-80. PubMed ID: 16204643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type.
    DeKruyff RH; Fang Y; Umetsu DT
    J Immunol; 1992 Dec; 149(11):3468-76. PubMed ID: 1358971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells.
    Croft M; Bradley LM; Swain SL
    J Immunol; 1994 Mar; 152(6):2675-85. PubMed ID: 7908301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKT cell-dependent regulation of secondary antigen-specific, conventional CD4+ T cell immune responses.
    Shin Y; Hong C; Lee H; Shin JH; Hong S; Park SH
    J Immunol; 2010 May; 184(10):5589-94. PubMed ID: 20375305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
    Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
    J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.